S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Ontrak (OTRK) Competitors

$0.25
-0.02 (-7.34%)
(As of 04/19/2024 ET)

OTRK vs. BRTX, MGRX, GBNHF, TNXP, MNPR, IMNN, BMRA, BNTC, SRNE, and CHEK

Should you be buying Ontrak stock or one of its competitors? The main competitors of Ontrak include BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), Greenbrook TMS (GBNHF), Tonix Pharmaceuticals (TNXP), Monopar Therapeutics (MNPR), Imunon (IMNN), Biomerica (BMRA), Benitec Biopharma (BNTC), Sorrento Therapeutics (SRNE), and Check-Cap (CHEK). These companies are all part of the "medical" sector.

Ontrak vs.

BioRestorative Therapies (NASDAQ:BRTX) and Ontrak (NASDAQ:OTRK) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, community ranking, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

Ontrak received 37 more outperform votes than BioRestorative Therapies when rated by MarketBeat users.

CompanyUnderperformOutperform
BioRestorative TherapiesN/AN/A
OntrakOutperform Votes
37
58.73%
Underperform Votes
26
41.27%

BioRestorative Therapies has a beta of 61.51, indicating that its stock price is 6,051% more volatile than the S&P 500. Comparatively, Ontrak has a beta of 2.43, indicating that its stock price is 143% more volatile than the S&P 500.

Ontrak has a consensus target price of $4.00, suggesting a potential upside of 1,423.81%. Given BioRestorative Therapies' higher probable upside, analysts plainly believe Ontrak is more favorable than BioRestorative Therapies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioRestorative Therapies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Ontrak
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, BioRestorative Therapies had 5 more articles in the media than Ontrak. MarketBeat recorded 15 mentions for BioRestorative Therapies and 10 mentions for Ontrak. Ontrak's average media sentiment score of 0.10 beat BioRestorative Therapies' score of -0.04 indicating that BioRestorative Therapies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BioRestorative Therapies
0 Very Positive mention(s)
2 Positive mention(s)
12 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ontrak
0 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

BioRestorative Therapies has higher earnings, but lower revenue than Ontrak. BioRestorative Therapies is trading at a lower price-to-earnings ratio than Ontrak, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioRestorative Therapies$150K62.74-$14.41M-$3.51-0.40
Ontrak$12.74M0.58-$51.57M-$6.17-0.04

69.4% of BioRestorative Therapies shares are owned by institutional investors. Comparatively, 13.0% of Ontrak shares are owned by institutional investors. 21.6% of BioRestorative Therapies shares are owned by company insiders. Comparatively, 1.2% of Ontrak shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Ontrak has a net margin of -261.48% compared to Ontrak's net margin of -9,873.97%. Ontrak's return on equity of -114.84% beat BioRestorative Therapies' return on equity.

Company Net Margins Return on Equity Return on Assets
BioRestorative Therapies-9,873.97% -114.84% -107.19%
Ontrak -261.48%-1,444.59%-129.49%

Summary

BioRestorative Therapies beats Ontrak on 10 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OTRK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OTRK vs. The Competition

MetricOntrakhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$7.40M$2.11B$4.80B$7.44B
Dividend YieldN/A2.19%2.99%4.01%
P/E Ratio-0.0415.08179.8714.31
Price / Sales0.586.132,584.3092.04
Price / CashN/A11.6846.7734.82
Price / Book0.213.404.594.20
Net Income-$51.57M$71.74M$103.72M$214.28M
7 Day Performance-31.15%1.18%-3.58%-3.10%
1 Month Performance-38.98%-4.46%-5.14%-3.61%
1 Year Performance-90.68%-21.70%7.53%4.00%

Ontrak Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BRTX
BioRestorative Therapies
2.3412 of 5 stars
$1.31
-0.8%
N/AN/A$8.87M$150,000.00-0.3710Gap Up
High Trading Volume
MGRX
Mangoceuticals
0 of 5 stars
$0.26
+4.0%
N/A-66.7%$6.12M$730,000.000.002
GBNHF
Greenbrook TMS
0 of 5 stars
$0.08
-27.0%
N/AN/A$4.37M$69.10M-0.04492Gap Down
TNXP
Tonix Pharmaceuticals
2.8655 of 5 stars
$0.15
flat
$5.50
+3,569.1%
-95.1%$12.67M$7.77M-0.02117Analyst Report
Gap Down
High Trading Volume
MNPR
Monopar Therapeutics
2.7919 of 5 stars
$0.73
-4.0%
$2.00
+174.7%
-47.0%$12.71MN/A-1.1911Positive News
Gap Down
IMNN
Imunon
2.6941 of 5 stars
$1.37
-6.8%
$13.00
+848.9%
-3.8%$12.88M$500,000.00-0.6331News Coverage
Gap Down
BMRA
Biomerica
0 of 5 stars
$0.74
-3.9%
N/A-53.9%$12.42M$5.34M-2.0062Earnings Report
BNTC
Benitec Biopharma
1.4862 of 5 stars
$4.78
-2.6%
$10.00
+109.2%
+64.3%$12.38M$80,000.000.0018News Coverage
SRNE
Sorrento Therapeutics
0 of 5 stars
$0.03
-26.7%
N/A-91.7%$12.98M$60.32M0.00799Gap Down
CHEK
Check-Cap
0 of 5 stars
$2.24
+2.8%
N/A+67.4%$13.10MN/A-0.7485

Related Companies and Tools

This page (NASDAQ:OTRK) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners